E Davids

Summary

Affiliation: University of Essen
Country: Germany

Publications

  1. ncbi Buprenorphine in the treatment of opioid dependence
    Eugen Davids
    Rhine Clinics Essen, Department of Psychiatry and Psychotherapy, University of Duisburg Essen, Virchowstr 174, 45147 Essen, Germany
    Eur Neuropsychopharmacol 14:209-16. 2004
  2. ncbi [Analysis of a special consultation for attention deficit/hyperactivity disorder in adults]
    E Davids
    Klinik für Psychiatrie und Psychotherapie der Universität Duisburg Essen, Rheinische Kliniken Essen
    Gesundheitswesen 66:416-22. 2004
  3. ncbi [Descriptive analysis of drug-related deaths over a 5-year period]
    Eugen Davids
    Klinik für Psychiatrie und Psychotherapie der Universität Essen, Rheinische Kliniken Essen
    Psychiatr Prax 30:266-71. 2003
  4. ncbi [Attention-deficit/hyperactivity disorder and substance abuse]
    Eugen Davids
    Rheinische Kliniken Essen, Klinik für Psychiatrie und Psychotherapie der Universität Duisburg Essen
    Psychiatr Prax 30:182-6. 2003
  5. ncbi [Atomoxetine for the treatment of attention-deficit/hyperactivity disorder]
    E Davids
    Klinik für Psychiatrie und Psychotherapie der Universität Duisburg Essen, Rheinische Kliniken Essen, Essen
    Fortschr Neurol Psychiatr 72:586-91. 2004
  6. ncbi [Life events and contact behaviour in drug-related death]
    E Davids
    Klinik für Psychiatrie und Psychotherapie der Universität Essen, Rheinische Kliniken Essen
    Fortschr Neurol Psychiatr 71:135-40. 2003
  7. ncbi Syndrome profiles in alcoholism and panic disorder with or without agoraphobia: an explorative family study
    Eugen Davids
    Department of Psychiatry University of Mainz, Mainz, Germany
    Prog Neuropsychopharmacol Biol Psychiatry 26:1079-87. 2002
  8. ncbi History of attention-deficit hyperactivity disorder symptoms and opioid dependence: a controlled study
    Eugen Davids
    Department of Psychiatry and Psychotherapy, University of Duisburg Essen, Rhine Clinics Essen, Virchowstr 174, 45147 Essen, Germany
    Prog Neuropsychopharmacol Biol Psychiatry 29:291-6. 2005
  9. ncbi Attention deficit hyperactivity disorder and borderline personality disorder
    Eugen Davids
    Department of Psychiatry and Psychotherapy, University of Duisburg Essen Rhine Clinics Essen Virchowstrasse 174, 45147 Essen, Germany
    Prog Neuropsychopharmacol Biol Psychiatry 29:865-77. 2005
  10. ncbi Organotypic rat cerebellar slice culture as a model to analyze the molecular pharmacology of GABAA receptors
    Eugen Davids
    Clinical Research Group, Department of Psychiatry, University of Mainz, Mainz, Germany
    Eur Neuropsychopharmacol 12:201-8. 2002

Detail Information

Publications23

  1. ncbi Buprenorphine in the treatment of opioid dependence
    Eugen Davids
    Rhine Clinics Essen, Department of Psychiatry and Psychotherapy, University of Duisburg Essen, Virchowstr 174, 45147 Essen, Germany
    Eur Neuropsychopharmacol 14:209-16. 2004
    ..Buprenorphine is an additional treatment option for heroin dependent patients, especially for those who do not wish to start or continue with methadone or for those who do not seem to benefit from adequate dosages of methadone...
  2. ncbi [Analysis of a special consultation for attention deficit/hyperactivity disorder in adults]
    E Davids
    Klinik für Psychiatrie und Psychotherapie der Universität Duisburg Essen, Rheinische Kliniken Essen
    Gesundheitswesen 66:416-22. 2004
    ..Guidelines need to be drawn up to establish handover from paediatric to adult ADHD care...
  3. ncbi [Descriptive analysis of drug-related deaths over a 5-year period]
    Eugen Davids
    Klinik für Psychiatrie und Psychotherapie der Universität Essen, Rheinische Kliniken Essen
    Psychiatr Prax 30:266-71. 2003
    ..The purpose of the study was to examine opiate-related deaths in the German town Essen (inhabitants about 600,000) from 1990-1994. Sociodemographic data, psychiatric comorbidity and purity of the used opioids were of focussed interest...
  4. ncbi [Attention-deficit/hyperactivity disorder and substance abuse]
    Eugen Davids
    Rheinische Kliniken Essen, Klinik für Psychiatrie und Psychotherapie der Universität Duisburg Essen
    Psychiatr Prax 30:182-6. 2003
    ..Possible pharmacological and non-pharmacological therapeutic strategies in patients with ADHD and substance abuse are discussed...
  5. ncbi [Atomoxetine for the treatment of attention-deficit/hyperactivity disorder]
    E Davids
    Klinik für Psychiatrie und Psychotherapie der Universität Duisburg Essen, Rheinische Kliniken Essen, Essen
    Fortschr Neurol Psychiatr 72:586-91. 2004
    ..Atomoxetine is the first nonstimulant approved by the FDA for the treatment of ADHD and the first medication approved for the treatment of adult ADHD...
  6. ncbi [Life events and contact behaviour in drug-related death]
    E Davids
    Klinik für Psychiatrie und Psychotherapie der Universität Essen, Rheinische Kliniken Essen
    Fortschr Neurol Psychiatr 71:135-40. 2003
    ..Turning away from the help system is not the reason for drug-related death, but an important attendant circumstance...
  7. ncbi Syndrome profiles in alcoholism and panic disorder with or without agoraphobia: an explorative family study
    Eugen Davids
    Department of Psychiatry University of Mainz, Mainz, Germany
    Prog Neuropsychopharmacol Biol Psychiatry 26:1079-87. 2002
    ..The presented method of analyzing syndrome profiles in a family study seems to be a possibility to demonstrate references to genetic links between patients and parents in anxiety- and alcohol-related disorders...
  8. ncbi History of attention-deficit hyperactivity disorder symptoms and opioid dependence: a controlled study
    Eugen Davids
    Department of Psychiatry and Psychotherapy, University of Duisburg Essen, Rhine Clinics Essen, Virchowstr 174, 45147 Essen, Germany
    Prog Neuropsychopharmacol Biol Psychiatry 29:291-6. 2005
    ..Patients with ADHD history seemed to experience a drug abuse career with more complications which need to be recognized with focused attention in order to start earlier treatment strategies...
  9. ncbi Attention deficit hyperactivity disorder and borderline personality disorder
    Eugen Davids
    Department of Psychiatry and Psychotherapy, University of Duisburg Essen Rhine Clinics Essen Virchowstrasse 174, 45147 Essen, Germany
    Prog Neuropsychopharmacol Biol Psychiatry 29:865-77. 2005
    ..From a neuropsychological point of view dissociation in BPD might be regarded as a special form of behavioral inhibition and sustained attention comparable to ADHD. Possible therapeutic strategies of comorbid ADHD and BPD are discussed...
  10. ncbi Organotypic rat cerebellar slice culture as a model to analyze the molecular pharmacology of GABAA receptors
    Eugen Davids
    Clinical Research Group, Department of Psychiatry, University of Mainz, Mainz, Germany
    Eur Neuropsychopharmacol 12:201-8. 2002
    ..In addition, these preparations can be utilized to study the pharmacological effects of GABA(A)/BZD selective drugs on postnatal development of GABA(A) receptors in rat cerebellum...
  11. ncbi A pilot clinical trial of oxcarbazepine in adults with attention-deficit hyperactivity disorder
    Eugen Davids
    Department of Psychiatry and Psychotherapy, Rhine Clinics Essen, University of Duisburg Essen, Virchowstr 174, 45147 Essen, Germany
    Prog Neuropsychopharmacol Biol Psychiatry 30:1033-8. 2006
    ..The results of this investigation indicate that oxcarbazepine may be a potentially useful agent for the treatment of ADHD in adults. However, placebo-controlled randomized trials are needed to provide evidence...
  12. ncbi Psychotropic drug prescription in a psychiatric university hospital in Germany
    Eugen Davids
    Department of Psychiatry and Psychotherapy, Rhine Clinics Essen, University of Duisburg Essen, Virchowstr 174, 45147 Essen, Germany
    Prog Neuropsychopharmacol Biol Psychiatry 30:1109-16. 2006
    ..Such surveys should be carried out more frequently and simultaneously in different centers. Critical comparisons could help to optimize treatment...
  13. ncbi Antipsychotic treatment of psychosis associated with multiple sclerosis
    Eugen Davids
    Department of Psychiatry and Psychotherapy, University of Duisburg Essen, Virchowstr 174, 45147, Germany
    Prog Neuropsychopharmacol Biol Psychiatry 28:743-4. 2004
    ..Risperidone was not administered with respect to possible EPS. However, ziprasidone was tolerated well and appeared to be effective...
  14. ncbi Changes in the treatment of acute psychosis in a German public hospital from 1998 to 2004
    Tiemo Wessels
    Rhine Clinics Essen, Department of Psychiatry and Psychotherapy, University of Duisburg Essen, Virchowstr 174, Essen 45147, Germany
    Psychiatr Q 78:91-9. 2007
    ..The aim of our study was to investigate antipsychotic treatment strategies in acute schizophrenic episodes in a German university hospital...
  15. ncbi [Escitalopram: a chiral agent for treatment of depression]
    Michael Overlack
    , Rheinische Kliniken Essen
    Med Monatsschr Pharm 27:148-51. 2004
  16. ncbi Neuropsychological assessment of adult patients with attention-deficit/hyperactivity disorder
    Bernhard W Müller
    Clinic for Psychiatry and Psychotherapy, University of Duisburg Essen, Virchowstrasse 174, 45147 Essen, Germany
    Eur Arch Psychiatry Clin Neurosci 257:112-9. 2007
    ..Adults with ADHD show indicators of lowered cognitive performance under medication. These are related more to memory and attention under high mental load than to response inhibition or simple attention or motor performance...
  17. ncbi A rare case of dependence on pemoline
    Udo Bonnet
    Klinik für Suchtmedizin und Abhängiges Verhalten, Rheinische Kliniken Essen, Universitat Duisburg Essen, Virchowstr 174, D 45147 Essen, Germany
    Prog Neuropsychopharmacol Biol Psychiatry 30:1340-1. 2006
    ..Therefore, this case confirms the experience that in the treatment of ADHD the high risk to develop a dependence on psychostimulants is combined with a history of stimulant abuse...
  18. ncbi Effects of norepinephrine and serotonin transporter inhibitors on hyperactivity induced by neonatal 6-hydroxydopamine lesioning in rats
    Eugen Davids
    Department of Psychiatry and Neuroscience Program, Harvard Medical School, Boston, MA, USA
    J Pharmacol Exp Ther 301:1097-102. 2002
    ....
  19. ncbi Serotonin transporter binding increases in caudate-putamen and nucleus accumbens after neonatal 6-hydroxydopamine lesions in rats: implications for motor hyperactivity
    Kehong Zhang
    Mailman Research Center, McLean Division of Massachusetts General Hospital, 115 Mill Street, Belmont, MA 02478, USA
    Brain Res Dev Brain Res 137:135-8. 2002
    ..These findings suggest that excess 5-HT transporters reflect serotonin hyperinnervation reported to occur in lesioned rats, and may modulate motor hyperactivity...
  20. ncbi Effects of dopamine D4 receptor-selective antagonists on motor hyperactivity in rats with neonatal 6-hydroxydopamine lesions
    Kehong Zhang
    Department of Psychiatry and Neuroscience Program, Harvard Medical School, Boston, MA 02115, USA
    Psychopharmacology (Berl) 161:100-6. 2002
    ..However, behavioral effects of this agent may not be attributed exclusively to D4 receptor blockade, since it interacts with other sites including serotonin receptors...
  21. ncbi Plasticity of dopamine D4 receptors in rat forebrain: temporal association with motor hyperactivity following neonatal 6-hydroxydopamine lesioning
    Kehong Zhang
    Mailman Research Center, McLean Division of Massachusetts General Hospital, 115 Mill Street, Belmont, MA 02478, USA
    Neuropsychopharmacology 26:625-33. 2002
    ..These results further support the hypothesis that D(4) receptors may play a pivotal role in lesion-induced hyperactivity, and possibly in clinical ADHD...
  22. ncbi Animal models of attention-deficit hyperactivity disorder
    Eugen Davids
    Department of Psychiatry and Neuroscience Program, Harvard Medical School, and Mailman Research Center, McLean Division of Massachusetts General Hospital, 115 Mill Street, Belmont, MA 02478-9106, USA
    Brain Res Brain Res Rev 42:1-21. 2003
    ..Improved models as well as further testing of their ability to predict treatment responses are required...
  23. ncbi Stereoselective effects of methylphenidate on motor hyperactivity in juvenile rats induced by neonatal 6-hydroxydopamine lesioning
    Eugen Davids
    Department of Psychiatry and Neuroscience Program, Harvard Medical School and Mailman Research Center, McLean Division of Massachusetts General Hospital, Belmont, MA 02478, USA
    Psychopharmacology (Berl) 160:92-8. 2002
    ..CONCLUSIONS: The more active enantiomer, as predicted, was d-methylphenidate, but the l-enantiomer interfered with its effects, suggesting that clinical potency of d-methylphenidate may be more than twice that of the racemate...